NABP Exam NAPLEX Topic 8 Question 51 Discussion

Actual exam question for NABP's North American Pharmacist Licensure Examination exam

Question #: 51
Topic #: 8

[All North American Pharmacist Licensure Examination Questions]

TM is a 78 YOW with a history of hypertension, hypercholesterolemia and arthritis was admitted for proximal arterial fibrillation.

While in the hospital she was placed on diltiazem drip and eventually, converted to oral diltiazem 240mg. Pt's home medication includes Simvastatin 40mg po daily , hydrochlorothiazide 25mg po daily , Lisinopril 20mg daily and Acetaminophen. Her LDL-C is 100mg /dL.

What would be the most appropriate change to make on her therapy?

AIncrease Simvastatin to 80mg po daily

BKeep Simvastatin at 40mg po daily

CChange Simvastatin 40mg to Atorvastatin 40mg po daily

DChange Simvastatin to Lovastatin 20mg po daily

EDiscontinue Statins.
Diltiazem has a major drug interaction with Simvastatin. Diltiazem is a CYP3A4 inhibitor, and since Simvastatin is metabolized by CYP3A4, its level can build up and the risk of myopathy increases. It is recommended to switch to a non-CYP3A inhibitor such as Pitavastatin, Pravastatin, or Rosuvastatin, and if Simvastatin is to be kept on it should not exceed 10 mg/day. The same interaction also exists with lovastatin, and the recommendation is to not exceed a total dose of 20 mg/day po of Lovastatin. Given the current options, the best choice is to change to Atorvstatin 40 mg po daily.

Show Suggested Answer

Suggested Answer: C

by Danica at Aug 21, 2022, 04:00 AM

Limited Time Offer

25%

Off

Get Premium NAPLEX Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

Submit Cancel

Currently there are no comments in this discussion, be the first to comment!